Columns | Column: Biopharmaceutical Perspectives

"Biopharmaceutical Perspectives” covers current cutting-edge methods and trends involving chromatography in the constantly evolving biopharmaceutical sector. Columnist Koen Sandra received a PhD degree in Biochemistry from the Ghent University, Belgium in 2005. After his PhD, he joined Pronota, a molecular diagnostics company where he was active in developing analytical platforms for disease biomarker discovery and in setting up external collaborations. In 2008, he joined RIC, a company that provides chromatographic, electrophoretic and mass spectrometric support to the chemical, life sciences and pharmaceutical industries, where he holds the position of CEO. As a non-academic scientist, Koen Sandra is author of over 50 highly cited scientific papers and has presented his work at numerous conferences as an invited speaker.

View Articles